Moshe Elkabets

5.1k citations
84 papers · 3.0k indexed · h-index 25
Topics
Immune Cell Function and Interaction (11 papers)Cancer Immunotherapy and Biomarkers (10 papers)Lung Cancer Treatments and Mutations (8 papers)
Partner nations
IsraelUnited StatesChina

In The Last Decade

Moshe Elkabets

78 papers receiving 2.9k citations

Peers

Moshe Elkabets
Comparison fields: 5 of 124
  • Molecular Biology 1.4k
  • Immunology 1.2k
  • Oncology 1.1k
  • Cancer Research 467
  • Pulmonary and Respiratory Medicine 295
Replace Junnian Zheng with:
Junnian Zheng China
Giovanni Germano Italy
Jack D. Bui United States
Jingwei Ma China
Anca Maria Cîmpean Romania
Mitomu Kioi Japan
Yi Xiao China
Yongsheng Wang China
Romain Boidot France
Tiziana Triulzi Italy
Moshe Elkabets relative to Junnian Zheng China Junnian Zheng's profile →
Citations per field
00.5×1.5×2.4×
Junnian Zheng · 1×
Citations per year

Countries citing papers authored by Moshe Elkabets

Since Specialization
Citations

This map shows the geographic impact of Moshe Elkabets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Elkabets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Elkabets more than expected).

Fields of papers citing papers by Moshe Elkabets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Elkabets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Elkabets. The network helps show where Moshe Elkabets may publish in the future.

Co-authorship network of co-authors of Moshe Elkabets

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Elkabets. A scholar is included among the top collaborators of Moshe Elkabets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Elkabets. Moshe Elkabets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 2
5 2
6 4
7 7
8 1
9 4
10 24
11 3
12 8
13 30
14 14
15 22
16 6
17 9
18 29
19 1
20 47

About Moshe Elkabets

Moshe Elkabets is a scholar working on Oncology, Immunology and Cancer Research, having authored 84 papers that have together received 3.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.1k citations) and Cancer Research (467 citations). Moshe Elkabets has collaborated with scholars based in Israel, United States and China. Frequent co-authors include Ron N. Apte, Elena Voronov, Shahar Dotan, Yakov Krelin, Yaron Carmi, Eli Reich, Maurizio Scaltriti, José Baselga, Charles A. Dinarello and Malka R. White. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026